HELM INTELLIGENCEJNJ
Preparing your analysis.
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Working on your request
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Investors should consider the company's strong growth metrics alongside its current valuation when evaluating Johnson & Johnson.
Johnson & Johnson has a market capitalization of $658.93B and a current stock price of $271.23, reflecting a 0.93% increase from the previous close of $268.73. The company's P/E ratio stands at 24.59 and its revenue has grown by 6.05% year-over-year. The stock has a 52-week high of $281.01 and a low of $185.
Some investors highlight Johnson & Johnson's impressive EPS growth of 90.50% year-over-year as a sign of strong profitability. Additionally, the company's strong return on equity (ROE) of 32.87% may indicate effective management and operational performance.
Conversely, some analysts express concerns about the stock's P/E ratio of 24.59, suggesting it may be overvalued relative to its growth prospects. Furthermore, the recent increase in stock price could be viewed as a correction after a 97% run-up, raising questions about sustainability.
Hold JNJ? See what it does to your whole book.
Connect a brokerage read-only and Helm shows JNJ next to everything you hold: how concentrated you are, what moved today, and a daily brief on all of it. Free, no card.
See JNJ in my portfolioHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Watch my tickers
Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.
Hold JNJ? See what it does to your whole book.
Connect a brokerage read-only and Helm shows JNJ next to everything you hold: how concentrated you are, what moved today, and a daily brief on all of it. Free, no card.
See JNJ in my portfolioJohnson & Johnson has a market capitalization of $658.93B and a current stock price of $271.23, reflecting a 0.93% increase from the previous close of $268.73. The company's P/E ratio stands at 24.59 and its revenue has grown by 6.05% year-over-year. The stock has a 52-week high of $281.01 and a low of $185.
Conversely, some analysts express concerns about the stock's P/E ratio of 24.59, suggesting it may be overvalued relative to its growth prospects. Furthermore, the recent increase in stock price could be viewed as a correction after a 97% run-up, raising questions about sustainability.
Some investors highlight Johnson & Johnson's impressive EPS growth of 90.50% year-over-year as a sign of strong profitability. Additionally, the company's strong return on equity (ROE) of 32.87% may indicate effective management and operational performance.
Some investors highlight Johnson & Johnson's impressive EPS growth of 90.50% year-over-year as a sign of strong profitability. Additionally, the company's strong return on equity (ROE) of 32.87% may indicate effective management and operational performance. Conversely, some analysts express concerns about the stock's P/E ratio of 24.59, suggesting it may be overvalued relative to its growth prospects. Furthermore, the recent increase in stock price could be viewed as a correction after a 97% run-up, raising questions about sustainability.
Johnson & Johnson has a market capitalization of $658.93B and a current stock price of $271.23, reflecting a 0.93% increase from the previous close of $268.73. The company's P/E ratio stands at 24.59 and its revenue has grown by 6.05% year-over-year. The stock has a 52-week high of $281.01 and a low of $185.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for JNJ at helmterminal.dev/analyze/JNJ, updated continuously during US market hours. No signup required.